EU Court Blocks Regulator From Releasing Drug Trial Data

Law360, New York (April 30, 2013, 3:11 PM ET) -- A European Union court has blocked the EU’s top drug regulator from granting third-party access to clinical trial information from InterMune Inc. and AbbVie Inc. drug approval applications, dealing a blow to its open document access policy, the watchdog announced Tuesday.

According to the European Medicines Agency, the EU’s General Court has granted interim rulings barring it from providing clinical study and other documents under two freedom of information requests related to marketing authorization applications for AbbVie’s blockbuster rheumatoid arthritis treatment Humira and InterMune’s treatment for...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers